Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of interleukins in the pathogenesis of pulmonary fibrosis
Yi Xin She, Qing Yu, Xiao Xiao Tang
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Virus infection induced pulmonary fibrosis
Wei Huang, Xiao Xiao Tang
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 110
Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review
Arwa A. Al-Qahtani, Fatimah S. Alhamlan, Ahmed A. Al‐Qahtani
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 1, pp. 13-13
Open Access | Times Cited: 89
The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis
Siavash Bolourani, Max Brenner, Ping Wang
Journal of Molecular Medicine (2021) Vol. 99, Iss. 10, pp. 1373-1384
Open Access | Times Cited: 71
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
Jamal Majidpoor, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112419-112419
Open Access | Times Cited: 57
Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
Hongbo Ma, Xuyi Wu, Yi Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 56
Irreversibility of Pulmonary Fibrosis
Qing Yu, Xiao Xiao Tang
Aging and Disease (2022) Vol. 13, Iss. 1, pp. 73-73
Open Access | Times Cited: 41
A four-part guide to lung immunology: Invasion, inflammation, immunity, and intervention
Indiwari Gopallawa, Ruchika Dehinwal, Vaibhav Bhatia, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 37
Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis
C.Y. Perrot, Τheodoros Karampitsakos, Jose D. Herazo‐Maya
AJP Cell Physiology (2023) Vol. 325, Iss. 4, pp. C1046-C1057
Open Access | Times Cited: 35
The role of inflammation in silicosis
Tong‐Tong Liu, Hai-Fei Sun, Yanxing Han, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 15
Vinpocetine alleviated alveolar epithelial cells injury in experimental pulmonary fibrosis by targeting PPAR-γ/NLRP3/NF-κB and TGF-β1/Smad2/3 pathways
Zeena Ayad Hussein, Ahmed R. Abu‐Raghif, Nibras J. Tahseen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Identification of ferroptosis-related lncRNAs for predicting prognosis and immunotherapy response in non-small cell lung cancer
Lin Yuan, Shengguo Sun, Qinhu Zhang, et al.
Future Generation Computer Systems (2024) Vol. 159, pp. 204-220
Closed Access | Times Cited: 13
Exploring the Complexities of Long COVID
Jackson Donald, Shymaa E. Bilasy, Catherine Yang, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1060-1060
Open Access | Times Cited: 11
The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view
Mihai Lazăr, Mihai Săndulescu, Ecaterina Constanța Barbu, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 639-639
Open Access | Times Cited: 9
Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction
Zhen Zheng, Fei Peng, Yong Zhou
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 2, pp. 72-79
Open Access | Times Cited: 9
Highlights on Future Treatments of IPF: Clues and Pitfalls
Alessandro Libra, Enrico Sciacca, Giuseppe Muscato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8392-8392
Open Access | Times Cited: 8
Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions
Megh Pravin Vithalkar, Shaili Pradhan, K. Sandra, et al.
Cell Biochemistry and Biophysics (2025)
Open Access | Times Cited: 1
Obesity and the Development of Lung Fibrosis
Xia Guo, Christudas Sunil, Guoqing Qian
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 34
The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis
Joe E. Mouawad, Carol Feghali‐Bostwick
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2963-2963
Open Access | Times Cited: 21
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8
Anindya Roy, Lei Shi, Ashley Chang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
The occurrence and development mechanisms of esophageal stricture: state of the art review
Fang Yang, Yiwei Hu, Zewen Shi, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Diesel exhaust particle exposure exacerbates ciliary and epithelial barrier dysfunction in the multiciliated bronchial epithelium models
Eunsook Park, Bu‐Yeo Kim, Seahyoung Lee, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 273, pp. 116090-116090
Open Access | Times Cited: 7
Regulation of macrophage activation by lactylation in lung disease
Yungeng Wei, Hua Guo, Shixing Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Macrophages in organ fibrosis: from pathogenesis to therapeutic targets
Yuanyuan Jiang, Rong Cai, Yu Huang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Single Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis
Amy Zhao, Avraham Unterman, Nebal Abu Hussein, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 10, pp. 1252-1266
Closed Access | Times Cited: 6
Soluble ECM promotes organotypic formation in lung alveolar model
Jonard Corpuz Valdoz, Nicholas A. Franks, Collin G. Cribbs, et al.
Biomaterials (2022) Vol. 283, pp. 121464-121464
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top